Unfractionated heparin-clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy.
Raffaele Bugiardini, Maria Dorobantu, Zorana Vasiljevic...
https://pubmed.ncbi.nlm.nih.gov/25988359Actively Recruiting
Led by University of Bologna · Updated on 2025-04-16
36000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are conducting the International Survey of Acute Coronary Syndromes (ISACS), an observational study designed to collect and analyze data from patients with acute coronary syndromes such as STEMI or NSTEMI. The study aims to document patient characteristics, in-hospital outcomes, and longer-term results at 6 months and 1 year. It also assesses invasive procedures, complications, and how well treatments follow established guidelines internationally. This study is non-interventional and serves as a patient registry. It collects detailed information from participating centers on treatment regimens and procedures without administering any specific therapies. The study covers both retrospective and prospective data gathering, focusing on outcomes and adherence to recommended care practices across multiple countries. Participants provide data through hospital records and follow-up evaluations at 30 days, 6 months, and 1 year. Researchers measure outcomes including all-cause mortality, cardiovascular deaths, recurrent heart attacks, and genetic studies related to clinical results. Adherence to guideline-recommended therapies is also monitored. The study is led by the University of Bologna and involves various international collaborators, with patient participation lasting up to one year after initial admission.
CONDITIONS
International Survey of Acute Coronary Syndromes
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Hospital stay duration
Participants diagnosed with acute coronary syndromes such as STEMI or NSTEMI are documented including invasive procedures and complications.
1 hospital admission visit
Duration - Up to 1 year
Participants are observed to document in-hospital outcomes and outcomes at 6 months and 1 year including mortality, recurrent myocardial infarction, and adherence to guideline-recommended therapies.
Visits or contacts at discharge, 6 months, and 1 year
Total: 1 location
1
University of Bologna
Bologna, Emilia-Romagna, Italy, 40138
Actively Recruiting
R
Raffaele Bugiardini, MD
L
Lina Badimon, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Raffaele Bugiardini, Maria Dorobantu, Zorana Vasiljevic...
https://pubmed.ncbi.nlm.nih.gov/25988359Raffaele Bugiardini, Edina Cenko, Beatrice Ricci...
https://pubmed.ncbi.nlm.nih.gov/26778165Edina Cenko, Beatrice Ricci, Sasko Kedev...
https://pubmed.ncbi.nlm.nih.gov/29474588Olivia Manfrini, Beatrice Ricci, Edina Cenko...
https://pubmed.ncbi.nlm.nih.gov/27381858Lucian Câlmâc, Vlad Bătăilă, Beatrice Ricci...
https://pubmed.ncbi.nlm.nih.gov/27381859Raffaele Bugiardini, Lina Badimon, ISACS-TC Investigators and Coordinators
https://pubmed.ncbi.nlm.nih.gov/27386758Edina Cenko, Beatrice Ricci, Sasko Kedev...
https://pubmed.ncbi.nlm.nih.gov/27499222Beatrice Ricci, Olivia Manfrini, Edina Cenko...
https://pubmed.ncbi.nlm.nih.gov/27506888Edina Cenko, Beatrice Ricci, Sasko Kedev...
https://pubmed.ncbi.nlm.nih.gov/27514628Raffaele Bugiardini, Beatrice Ricci, Edina Cenko...
https://pubmed.ncbi.nlm.nih.gov/28862963